Title:
miR-155 INHIBITORS FOR TREATING CUTANEOUS T CELL LYMPHOMA (CTCL)
Document Type and Number:
Japanese Patent JP2020094073
Kind Code:
A
Abstract:
To provide miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL).SOLUTION: The present invention provides oligonucleotide inhibitors of miR-155 and compositions thereof. The invention further provides methods for treating cancer such as a T cell lymphoma in a subject by administering to the subject an oligonucleotide inhibitor of miR-155. The invention also provides methods for reducing or inhibiting the proliferation of malignant T cells by administering an oligonucleotide inhibitor of miR-155.SELECTED DRAWING: None
Inventors:
DAVID RODMAN
ANITA SETO
CHRISTINA DALBY
AIMEE JACKSON
XUAN BEATTY
ANITA SETO
CHRISTINA DALBY
AIMEE JACKSON
XUAN BEATTY
Application Number:
JP2020054154A
Publication Date:
June 18, 2020
Filing Date:
March 25, 2020
Export Citation:
Assignee:
MIRAGEN THERAPEUTICS INC
International Classes:
A61K31/7088; A61K31/192; A61K45/00; A61P35/00; A61P35/02; A61P43/00; C12Q1/6851
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto
Natsuki Morishita
Takatoshi Iida
Daisuke Ishikawa
Kensaku Yamamoto